Market revenue in 2021 | USD 493.5 million |
Market revenue in 2030 | USD 2,165.5 million |
Growth rate | 17.9% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.3% in 2021. Horizon Databook has segmented the U.S. ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. was the largest market in North America and contributed to around 85% of the market share in 2020. This can be attributed to increasing adoption of technologically advanced solutions in the country for clinical trials.
Furthermore, healthcare, and pharmaceutical industry in the U.S. has been the pioneer in development of new medicines, thereby proving to be one of the major investors for R&D processes. In addition, presence of well-established pharmaceutical companies that are adopting technologically advanced solutions for clinical trials is boosting the market growth.
Furthermore, market players are adopting strategies to be competitive in the market such as introduction of new products to ease the process of conducting clinical trials, geographic expansion, addition of new services in their portfolios, and collaborations.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into U.S. ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account